Deutsch English Français

Contact

EP3158043

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3158043

EP3158043 - COMPOSITIONS CONTAINING ONE OR MORE POLY ALPHA-1,3-GLUCAN ETHER COMPOUNDS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 14.01.2022 Database last updated on 03.09.2024
Former	The patent has been granted Status updated on 05.02.2021
Former	Grant of patent is intended Status updated on 15.10.2020
Former	Examination is in progress Status updated on 21.09.2019
Former	Request for examination was made Status updated on 24.03.2017
Former	The international publication has been made Status updated on 18.11.2016
Most recent event Tooltip	27.04.2024	Lapse of the patent in a contracting state New state(s): MK	published on 29.05.2024 [2024/22]
Applicant(s)	For all designated states Nutrition & Biosciences USA 4, Inc. 3490 Winton Place Rochester NY 14623 / US
	[2021/01]
Former [2020/01]	For all designated states DuPont Industrial Biosciences USA, LLC Chestnut Run Plaza 974 Centre Road Wilmington, Delaware 19805 / US
Former [2017/17]	For all designated states E. I. du Pont de Nemours and Company Chestnut Run Plaza 974 Centre Road P.O. Box 2915 Wilmington, DE 19805 / US
Inventor(s)	01 / NAGY, Kevin D. 106 Steven Lane Wilmington, Delaware 19808 / US
	02 / CAIMI, Perry G. 7 Holly Drive Kennett Square, Pennsylvania 19348 / US
	03 / DENNES, T. Joseph 425 West Eighth Avenue Parkesburg, Pennsylvania 19365 / US
	04 / HENNESSEY, Susan Marie 32 Truman Lane Avondale, Pennsylvania 19311 / US
	05 / POULOSE, Ayrookaran J. 2848 Wakefield Drive Belmont, California 94002 / US
	06 / PAULLIN, Jayme L. 2308 Wilson Avenue Claymont, Delaware 19703 / US
	[2017/17]
Representative(s)	Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB
	[2021/10]
Former [2017/17]	Matthews, Derek Peter Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD / GB
Application number, filing date	15739050.1	17.06.2015
	[2017/17]
	WO2015US36193
Priority number, date	US201462014318P	19.06.2014 Original published format: US 201462014318 P
	[2017/17]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2015195777
	Date:	23.12.2015
	Language:	EN
	[2015/51]
	Type:	A1 Application with search report
	No.:	EP3158043
	Date:	26.04.2017
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 23.12.2015 takes the place of the publication of the European patent application.
	[2017/17]
	Type:	B1 Patent specification
	No.:	EP3158043
	Date:	10.03.2021
	Language:	EN
	[2021/10]
Search report(s)	International search report - published on:	EP	23.12.2015
Classification	IPC:	C11D3/00, C11D3/22, C11D3/386, A61K8/66, A61K8/73	[2017/17]
	CPC:	A61K8/66 (EP,US); C11D3/38645 (US); A61K8/73 (EP,US); A61Q19/00 (EP,US); C11D3/225 (EP,US); C11D3/386 (EP); (+) C11D3/38627 (EP); D06M15/03 (EP,US); D06M16/00 (US); D06M16/003 (EP,US); A61K2800/10 (EP,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/17]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	MA	Not yet paid
Title	German:	ZUSAMMENSETZUNGEN MIT EINER ODER MEHREREN POLY-ALPHA-1,3-GLUCAN-ETHER-VERBINDUNGEN	[2017/17]
	English:	COMPOSITIONS CONTAINING ONE OR MORE POLY ALPHA-1,3-GLUCAN ETHER COMPOUNDS	[2017/17]
	French:	COMPOSITIONS CONTENANT UN OU PLUSIEURS COMPOSÉS D'ÉTHER DE POLY ALPHA-1,3-GLUCANE	[2017/17]
Entry into regional phase	19.12.2016	National basic fee paid
	19.12.2016	Designation fee(s) paid
	19.12.2016	Examination fee paid
Examination procedure	19.12.2016	Examination requested [2017/17]
	19.12.2016	Date on which the examining division has become responsible
	03.08.2017	Amendment by applicant (claims and/or description)
	25.09.2019	Despatch of a communication from the examining division (Time limit: M04)
	17.01.2020	Reply to a communication from the examining division
	16.10.2020	Communication of intention to grant the patent
	28.01.2021	Fee for grant paid
	28.01.2021	Fee for publishing/printing paid
	28.01.2021	Receipt of the translation of the claim(s)
Divisional application(s)	EP21161464.9 / EP3919599
Opposition(s)	13.12.2021	No opposition filed within time limit [2022/07]
Fees paid	Renewal fee
	16.06.2017	Renewal fee patent year 03
	12.06.2018	Renewal fee patent year 04
	13.06.2019	Renewal fee patent year 05
	15.06.2020	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	17.06.2015
	AL	10.03.2021
	AT	10.03.2021
	CY	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	MK	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SI	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IE	17.06.2021
	LU	17.06.2021
	BE	30.06.2021
	CH	30.06.2021
	LI	30.06.2021
	IS	10.07.2021
	PT	12.07.2021
	[2024/22]
Former [2023/30]	HU	17.06.2015
	AL	10.03.2021
	AT	10.03.2021
	CY	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SI	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IE	17.06.2021
	LU	17.06.2021
	BE	30.06.2021
	CH	30.06.2021
	LI	30.06.2021
	IS	10.07.2021
	PT	12.07.2021
Former [2023/29]	HU	17.06.2015
	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SI	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IE	17.06.2021
	LU	17.06.2021
	BE	30.06.2021
	CH	30.06.2021
	LI	30.06.2021
	IS	10.07.2021
	PT	12.07.2021
Former [2022/34]	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SI	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IE	17.06.2021
	LU	17.06.2021
	BE	30.06.2021
	CH	30.06.2021
	LI	30.06.2021
	IS	10.07.2021
	PT	12.07.2021
Former [2022/23]	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SI	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IE	17.06.2021
	LU	17.06.2021
	CH	30.06.2021
	LI	30.06.2021
	IS	10.07.2021
	PT	12.07.2021
Former [2022/21]	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SI	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IE	17.06.2021
	LU	17.06.2021
	CH	30.06.2021
	LI	30.06.2021
	PT	12.07.2021
Former [2022/18]	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SI	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	LU	17.06.2021
	PT	12.07.2021
Former [2022/13]	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SI	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	PT	12.07.2021
Former [2022/10]	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	PT	12.07.2021
Former [2022/08]	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	DK	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IS	10.07.2021
	PT	12.07.2021
Former [2022/07]	AL	10.03.2021
	AT	10.03.2021
	CZ	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	MC	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IS	10.07.2021
	PT	12.07.2021
Former [2021/52]	AT	10.03.2021
	CZ	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	NL	10.03.2021
	PL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IS	10.07.2021
	PT	12.07.2021
Former [2021/51]	AT	10.03.2021
	CZ	10.03.2021
	EE	10.03.2021
	ES	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	NL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	IS	10.07.2021
	PT	12.07.2021
Former [2021/50]	AT	10.03.2021
	CZ	10.03.2021
	EE	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	NL	10.03.2021
	RO	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SK	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
	PT	12.07.2021
Former [2021/48]	AT	10.03.2021
	CZ	10.03.2021
	EE	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	NL	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
Former [2021/46]	AT	10.03.2021
	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	NL	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	SM	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
Former [2021/43]	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	NL	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
Former [2021/38]	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	RS	10.03.2021
	SE	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
Former [2021/37]	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	LV	10.03.2021
	RS	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
Former [2021/36]	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	BG	10.06.2021
	NO	10.06.2021
	GR	11.06.2021
Former [2021/35]	FI	10.03.2021
	HR	10.03.2021
	LT	10.03.2021
	NO	10.06.2021
Former [2021/33]	FI	10.03.2021
	LT	10.03.2021
	NO	10.06.2021
Cited in	International search	[AD]GB2095275 (KAO CORP) [AD] 1-15 * claim 1 * * page 7, lines 39-47 * * examples 1-3,5 *;
		[E]WO2015095046 (DU PONT [US]) [E] 1-15 * claims 1-16 * * page 20, line 1 - page 23, line 17 * * page 60, lines 9-19 *;
		[E]WO2015095358 (DU PONT [US]) [E] 1,5-15 * claims 1-16 * * page 24, line 27 - page 28, line 13 ** page 65, lines 9-19 *;
		[A] - KIHO T ET AL, "(1----3)-alpha-D-glucan from an alkaline extract of Agrocybe cylindracea, and antitumor activity of its O-(carboxymethyl)ated derivatives", CARBOHYDRATE RESEARCH, PERGAMON, GB, (19890615), vol. 189, doi:10.1016/0008-6215(89)84103-5, ISSN 0008-6215, pages 273 - 279, XP002720169 [A] 1-15 * abstract * * page 278 * DOI: http://dx.doi.org/10.1016/0008-6215(89)84103-5
	Examination	EP3157640
	by applicant	GB1296839
		US3844890
		GB1372034
		GB1483591
		US4106991
		EP0035478
		GB2095275
		US4435307
		US4462917
		US4464270
		US4477360
		US4580421
		EP0218272
		US4661452
		US4689297
		EP0238216
		EP0258068
		EP0260105
		WO8809367
		US4794661
		US4799550
		EP0305216
		JPS6474992
		WO8906270
		EP0331376
		WO9009446
		EP0407225
		WO9100353
		WO9116422
		WO9205249
		WO9206221
		WO9206165
		WO9206154
		EP0495257
		WO9221760
		EP0531372
		EP0531315
		WO9324618
		WO9401541
		WO9402597
		WO9407998
		USRE34606E
		WO9412621
		US5324649
		WO9418314
		US5340735
		WO9425578
		WO9501426
		WO9506720
		WO9510603
		WO9510602
		WO9514783
		WO9522615
		WO9523221
		WO9524471
		WO9526397
		US5457046
		WO9530744
		WO9535381
		WO9535382
		WO9600292
		WO9605295
		US5500364
		WO9611262
	WO9612012
	WO9613580
	WO9623874
	WO9623873
	WO9627002
	WO9629397
	WO9630481
	WO9703161
	WO9704079
	WO9707202
	WO9710342
	US5648263
	WO9741213
	US5686593
	WO9743424
	US5691178
	US5700676
	WO9808940
	WO9812307
	WO9815257
	US5763254
	WO9826078
	US5776757
	US5776435
	US5801039
	US5814501
	US5855625
	WO9902702
	WO9909183
	WO9914341
	WO9914342
	WO9919467
	WO9923211
	WO9929876
	WO9933960
	WO9934003
	WO9942567
	US5945394
	WO9943793
	WO9943794
	WO9946399
	US5955340
	WO0029560
	WO0060060
	WO0060058
	WO0060059
	WO0114629
	WO0114532
	WO0134899
	WO0134784
	WO0164852
	WO0166712
	US6312936
	WO0185888
	WO0188107
	WO0196537
	WO0210355
	US2002022006
	WO0231124
	US6440991
	US6482628
	WO02092797
	US6562612
	US6566114
	US6579840
	US6602842
	WO03089562
	US6730646
	WO2004113551
	WO2005001064
	WO2005003311
	WO2005018336
	WO2005019443
	WO2005056782
	WO2005056783
	WO2005066338
	US6933140
	WO2006007911
	WO2006012899
	WO2006012902
	US7000000
	US7001878
	US7012053
	WO2006031554
	WO2006045391
	US7056880
	WO2006063594
	US2006134025
	WO2006066594
	WO2006066596
	US7138263
	WO2006136161
	WO2007044993
	EP1504994
	WO2007106293
	WO2008000825
	WO2008000567
	US2008057007
	US2008090747
	WO2008063400
	WO2008088493
	WO2008087426
	WO2008092919
	WO2008101894
	WO2008106214
	WO2008106215
	WO2009058303
	WO2009058661
	WO2009061381
	US7534759
	WO2009100102
	WO2009098659
	WO2009098660
	US7576048
	US2009209445
	EP2100949
	WO2009112992
	US7595182
	WO2009124160
	US7604974
	WO2009140504
	WO2009149200
	WO2009149144
	WO2009149145
	WO2009149419
	WO2009152031
	US2010081598
	WO2010056640
	WO2010056653
	WO2010059413
	WO2010059483
	WO2010088447
	WO2010088112
	WO2010091221
	WO2010090915
	WO2010104675
	WO2010115021
	WO2010117511
	WO2010116139
	WO2010135238
	WO2011072099
	WO2011076123
	WO2011076897
	WO2011080352
	WO2011080353
	WO2011080354
	WO2011082425
	WO2011082429
	WO2011087836
	WO2011094687
	WO2011094690
	WO2011098531
	WO2011127102
	WO2011140364
	WO2011163428
	WO2012027404
	WO2012059336
	WO2012104613
	EP1740690
	WO2012151534
	US8530219
	US2013244288
	US2013244287
	US8541041
	US8540971
	US8569033
	US8575083
	US2014179913
	- SIMPSON, MICROBIOLOGY, (1995), vol. 141, pages 1451 - 1460
	- CANTAREL ET AL., NUCLEIC ACIDS RES., (2009), vol. 37, pages D233 - 238
	- DARTOIS ET AL., BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1131, pages 253 - 360
	- YAMAGUCHI, GENE, (1991), vol. 103, pages 61 - 67
	- SCHIMADA ET AL., J. BIOCHEM., (1989), vol. 106, pages 383 - 388
	- HASS ET AL., GENE, (1991), vol. 109, pages 117 - 113
	- KUGIMIYA, BIOSCI. BIOTECH. BIOCHEM., (1992), vol. 56, pages 716 - 719
	- HAGE ET AL., NATURE, (1994), vol. 369, pages 637 - 639
	- DUBOIS ET AL., ANAL. CHEM., (1956), vol. 28, pages 350 - 356
	- ZEMLJI6 ET AL., LENZINGER BERICHTE, (2006), vol. 85, pages 68 - 76

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p